Inogen (INGN) Cost of Revenue (2013 - 2026)
Inogen (INGN) posted quarterly Cost of Revenue of $47.2 million for Q1 2026, up 2.91% year-over-year from $45.9 million in Q1 2025, and up 1.64% quarter-over-quarter from $46.5 million in Q4 2025.
Inogen (INGN) Cost of Revenue (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Cost of Revenue for 14 consecutive years, with $47.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 2.91% year-over-year to $47.2 million; the TTM figure through Mar 2026 stood at $195.7 million (up 6.84% YoY), while the FY2025 annual figure was $194.4 million, up 7.43% from the prior year.
- Cost of Revenue rose to $47.2 million in Q1 2026 per INGN's latest filing, from $46.5 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $62.6 million in Q3 2022 and bottomed at $41.4 million in Q1 2023.
- Historically, Cost of Revenue has averaged $49.1 million across 5 years, with a median of $47.5 million in 2024.
- Annual changes were most pronounced in 2022 — Cost of Revenue jumped 55.02% — and 2023, when it dropped 19.79%.
- Inogen's Cost of Revenue stood at $58.6 million in 2022, then declined by 18.56% to $47.7 million in 2023, then retreated by 8.27% to $43.8 million in 2024, then grew by 6.15% to $46.5 million in 2025, then grew by 1.64% to $47.2 million in 2026.
- Business Quant data shows INGN's Cost of Revenue at $47.2 million in Q1 2026, $46.5 million in Q4 2025, and $51.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Inogen | 152.80 Mn | 47.27 Mn | 43.27 Mn | 51.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.81 Mn |
| Jun 30, 2026 | 51.81 Mn |
| Mar 31, 2026 | 47.25 Mn |
| Mar 31, 2026 | 47.25 Mn |
| Dec 31, 2025 | 46.49 Mn |
| Dec 31, 2025 | 46.49 Mn |
| Sep 30, 2025 | 51.07 Mn |
| Sep 30, 2025 | 51.07 Mn |
| Jun 30, 2025 | 50.94 Mn |
| Jun 30, 2025 | 50.94 Mn |
| Mar 31, 2025 | 45.91 Mn |
| Mar 31, 2025 | 45.91 Mn |
| Dec 31, 2024 | 43.79 Mn |
| Dec 31, 2024 | 43.79 Mn |
| Sep 30, 2024 | 47.49 Mn |
| Sep 30, 2024 | 47.49 Mn |
| Jun 30, 2024 | 46.03 Mn |
| Jun 30, 2024 | 46.03 Mn |
| Mar 31, 2024 | 43.65 Mn |
| Mar 31, 2024 | 43.65 Mn |